ASTM Key Stats
- Aastrom Biosciences to Host Fourth Quarter 2013 Investor Call on March 13, 2014 noodls 03/06 17:47 ET
- 4:06 pm Aastrom Biosciences enters into $15 mln equity commitment with Lincoln Park Capital 01/27 18:24 ET
- AASTROM BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity S 01/27 16:12 ET
- Aastrom Biosciences Enters Into $15 Million Equity Commitment With Lincoln Park Capital GlobeNewswire 01/27 16:05 ET
- AASTROM BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib 01/14 17:09 ET
- Zacks #1 Rank Additions for Monday - Tale of the Tape Zacks 01/13 03:30 ET
- Incyte (INCY) Jumps: Stock Rises 6.8% - Tale of the Tape Zacks 01/13 02:57 ET
- 5 Stocks Under $10 Set to Soar 01/10 07:00 ET
- 5 Stocks Under $10 Set to Soar The Street 01/09 17:28 ET
- Peregrine Pharmaceuticals (PPHM) Soars: Stock Adds 14.5% in Session - Tale of the Tape Zacks 01/07 02:57 ET
ASTM Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Aastrom Biosciences is down 84.81% over the last year vs S&P 500 Total Return up 24.21%, Cytori Therapeutics up 10.07%, and International Stem Cell down 19.64%.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for ASTM
Pro Strategies Featuring ASTM
Did Aastrom Biosciences make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: United States
- Headquarters State/Province: Michigan
- Incorporation Country: United States
- Incorporation State/Province: Michigan
Aastrom Biosciences, Inc., is a regenerative medicine company that is engaged in the development of innovative cell therapies to repair or regenerate damaged or diseased tissues.